✦ LIBER ✦

Intravesical Adriamycin chemotherapy in bladder cancer

✍ Scribed by Yosuke Matsumura; Yujiro Ozaki; Hiroyuki Ohmori

Publisher: Springer
Year: 1983
Tongue: English
Weight: 469 KB
Volume: 11
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00256723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy with early intrave

Adjuvant chemotherapy with early intravesical instillation of Adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer

✍ Toyofumi Ueda; Seiji Naito; Atsushi Iguchi; Kazuyuki Sagiyama; Yukio Osada; Asam 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 546 KB

The 4th study of prophylactic intravesic

The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

✍ Yosuke Matsumura; Hideyuki Akaza; Shigeo Isaka; Susumu Kagawa; Kenkichi Koiso; T 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 397 KB

Intravesical chemotherapy in urinary bla

Intravesical chemotherapy in urinary bladder cancer

✍ Folke Edsmyr; Lennart Anderson; Pier-Luigi Esposti 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 153 KB

Intravesical chemotherapy with 4′-epi-Ad

Intravesical chemotherapy with 4′-epi-Adriamycin in patients with superficial bladder tumors

✍ Yosuke Matsumura; Tomoyasu Tsushima; Yujiro Ozaki; Jun Yoshimoto; Takafumi Akagi 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 203 KB

Intra-arterial Adriamycin chemotherapy f

Intra-arterial Adriamycin chemotherapy for bladder cancer

✍ Takeshi Uyama; Shoosuke Moriwaki; Masataka Yonezawa; Jiro Fujita 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 605 KB

Treatment of superficial bladder cancer

Treatment of superficial bladder cancer with intravesical chemotherapy

✍ Robert A. Badalament; Riad N. Farah 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Proper care of patients with superficial bladder cancer requires the assessment of multiple factors, including an understanding of the natural history of this disease, accurate clinical staging, and the expected efficacy of each drug. The pharmacology of intravesical mytomycin C is discussed in deta